Form 8-K · Current report
Moody's Corporation 8-K, filed Jul 22, 2026
- Filed
- CIK
- 0001059556
- Accession no.
- 0001628280-26-049104
Summary
Moody's Corporation reported second-quarter 2026 revenue of $2.2 billion, up 15% from a year earlier, with diluted EPS up 57%, and narrowed its full-year adjusted diluted EPS guidance to $16.50–$17.00 while raising share repurchase guidance to up to $3.0 billion. CEO Rob Fauber said customers are turning to the company for risk, data and analytics as capital markets evolve and AI transforms workflows.
Key points
- MCO revenue was $2,185 million, up 15% year over year, and adjusted operating margin expanded 440 basis points to 55.3%.
- Moody's Investors Service revenue rose 25% to $1,260 million, while Moody's Analytics revenue rose 4% to $925 million with Annualized Recurring Revenue up 9% to $3.7 billion.
- Moody's repurchased about $2.2 billion of shares year-to-date and returned roughly $2.5 billion to shareholders in the first half of 2026.
- The board declared a quarterly dividend of $1.03 per share, payable September 4, 2026, to shareholders of record on August 14, 2026.
Written by an AI model from the filing text. It can be incomplete or wrong; the filing on SEC.gov is the record.
Items reported
- 2.02Results of Operations and Financial Condition
- 7.01Regulation FD Disclosure
- 9.01Financial Statements and Exhibits
From the filing
ITEM 2.02 RESULTS OF OPERATIONS AND FINANCIAL CONDITION 3 ITEM 7.01 REGULATION FD DISCLOSURE 3 ITEM 9.01 FINANCIAL STATEMENTS AND EXHIBITS 3 SIGNATURES 4 EXHIBIT 99.1 2 Item 2.02, "Results of Operations and Financial Condition" On July 22, 2026, Moody's Corporation (the "Registrant") announced its financial results for the quarter ended June 30, 2026, as well as its outlook for 2026. A copy of the press release containing the announcement is included as Exhibit 99.1. …
An excerpt of the text as filed with the SEC, cut for length.
Readster writes AI-generated summaries of public filings for research purposes only. Summaries can be incomplete or wrong — check the original filing on SEC.gov before relying on it. Nothing here is investment, legal or medical advice.